Tech Company Financing Transactions
Gliknik Funding Round
Gliknik closed a $5 million Series B venture capital round on 4/29/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/29/2013
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
801 West Baltimore St. 501A
Baltimore, MD 21201
USA
Baltimore, MD 21201
USA
Phone
Website
Email Address
Not Recorded
Overview
Gliknik develops therapies for patients with cancer and immune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Block
Vice President
Henrik Olsen
VP - Bus. Development
Jeffrey Herpst
Browse more venture capital transactions:
Prev: 4/29/2013: RainDance Technologies venture capital transaction
Next: 4/29/2013: Solar Mosaic venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs